Published in J Pharm Sci on January 01, 2008
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99
Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci (2009) 1.31
Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. Bioconjug Chem (2008) 1.27
Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro. Biochemistry (2009) 1.06
Optical probes and techniques for O2 measurement in live cells and tissue. Cell Mol Life Sci (2012) 1.02
A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem (2009) 0.92
Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes. Mol Ther (2010) 0.89
Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials. ACS Nano (2013) 0.88
Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death. Mol Pharm (2010) 0.88
Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Mol Pharm (2011) 0.86
Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigen. Chembiochem (2014) 0.86
Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides. J Biol Chem (2010) 0.85
Optical oxygen micro- and nanosensors for plant applications. Sensors (Basel) (2012) 0.82
Multi-ligand poly(L-lactic-co-glycolic acid) nanoparticles inhibit activation of endothelial cells. J Cardiovasc Transl Res (2013) 0.81
Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles. Cancer Lett (2012) 0.81
The non-peptidic part determines the internalization mechanism and intracellular trafficking of peptide amphiphiles. PLoS One (2013) 0.79
Quo vadis radiotherapy? Technological advances and the rising problems in cancer management. Biomed Res Int (2013) 0.78
Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8. Mol Ther (2011) 0.77
Identification and characterization of a novel cell-penetrating peptide. Biochem Biophys Res Commun (2008) 0.77
Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane. AAPS J (2015) 0.76
Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods Mol Biol (2015) 0.76
Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit. PLoS One (2012) 0.76
Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study. J Biophys (2017) 0.75
Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors. PLoS One (2015) 0.75
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. Pharmaceuticals (Basel) (2010) 0.75
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain. Pharmaceuticals (Basel) (2010) 0.75
Delivery of mirror image polypeptides into cells. Chem Sci (2014) 0.75
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Silk fibroin as a vehicle for drug delivery applications. J Control Release (2010) 1.40
Silk fibroin spheres as a platform for controlled drug delivery. J Control Release (2008) 1.35
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci (2008) 1.23
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 1.17
Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release (2007) 1.12
Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake. Pharm Res (2002) 1.12
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
Transport of surface-modified nanoparticles through cell monolayers. Chembiochem (2005) 1.08
Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry (2005) 1.08
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials (2009) 1.03
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res (2003) 1.03
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Adv Drug Deliv Rev (2013) 1.02
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials (2009) 0.98
Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res (2003) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm (2003) 0.97
Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery. Angew Chem Int Ed Engl (2003) 0.96
Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm Res (2007) 0.95
Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials (2009) 0.95
Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm (2012) 0.94
DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev (2005) 0.94
The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity. Biochemistry (2006) 0.94
Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater (2008) 0.93
Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue. Ann Biomed Eng (2007) 0.91
Microparticle-mediated transfection of non-phagocytic cells in vitro. J Drug Target (2002) 0.90
The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials (2006) 0.90
The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials (2009) 0.88
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev (2009) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures. AAPS J (2008) 0.86
Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir (2008) 0.86
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm (2008) 0.86
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials (2006) 0.85
Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target (2003) 0.85
One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release (2005) 0.85
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. Ultrason Sonochem (2004) 0.85
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials (2003) 0.84
Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. Pharm Res (2004) 0.84
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res (2007) 0.82
Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials (2002) 0.81
Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research. Crit Rev Ther Drug Carrier Syst (2007) 0.81
Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res (2005) 0.81
Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. Biophys J (2005) 0.80
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci (2003) 0.80
On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm Res (2002) 0.80
Hydrogel nerve conduits produced from alginate/chitosan complexes. J Biomed Mater Res A (2007) 0.80
Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm Res (2004) 0.80
Design and validation of a novel bioreactor principle to combine online micro-computed tomography monitoring and mechanical loading in bone tissue engineering. Rev Sci Instrum (2010) 0.79
Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm Res (2004) 0.79
Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. Chembiochem (2002) 0.79
Immobilisation of GM-CSF onto particulate vaccine carrier systems. Int J Pharm (2004) 0.79
Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). Biochim Biophys Acta (2005) 0.79
A crystal clear solution for insulin delivery. Nat Biotechnol (2002) 0.79
Transfection of a mouse dendritic cell line by plasmid DNA-loaded PLGA microparticles in vitro. Eur J Pharm Biopharm (2004) 0.78
Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep. Eur J Pharm Biopharm (2013) 0.78
Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. Biomaterials (2011) 0.78
Stable stealth function for hollow polyelectrolyte microcapsules through a poly(ethylene glycol) grafted polyelectrolyte adlayer. Biomacromolecules (2007) 0.77
Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. Eur J Pharm Biopharm (2013) 0.77
The effect of hyaluronic acid on silk fibroin conformation. Biomaterials (2007) 0.77
Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells. Expert Rev Vaccines (2002) 0.76
Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction. Eur J Pharm Biopharm (2005) 0.76
Phagocytosis of poly(L-lysine)-graft-poly(ethylene glycol) coated microspheres by antigen presenting cells: Impact of grafting ratio and poly(ethylene glycol) chain length on cellular recognition. Biointerphases (2006) 0.76
Compromised integrity of excised porcine intestinal epithelium obtained from the abattoir affects the outcome of in vitro particle uptake studies. Eur J Pharm Sci (2002) 0.75
In vitro assessment of intestinal IGF-I stability. J Pharm Sci (2002) 0.75
Dendronised block copolymers as potential vectors for gene transfection. Org Biomol Chem (2008) 0.75
Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres. J Allergy Clin Immunol (2004) 0.75
Effects of structural modification on gene transfection and self-assembling properties of amphiphilic dendrimers. Org Biomol Chem (2006) 0.75
Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts. J Control Release (2012) 0.75